| Patient | Sugar Ray Robinson |
|---|---|
| Date of birth | 1963-05-03 |
| Identifiers | MRN HR-BX003-SYN; SSN (made up) 000-03-9318 |
| Document date | 2026-09-08 |
| Author | Langston Pryce-Okonjo, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Periodic adult preventive visit. [S]
Sugar Ray Robinson is a man of 63 with mild dementia due to Alzheimer's disease, type 2 diabetes and hypertension who comes with his care partner for his yearly preventive visit, three weeks after the diagnosis was explained to him. He takes donepezil 5 mg at bedtime without side effects so far, and he no longer takes glipizide; his home glucose readings run 120 to 170 mg/dL with no low readings. He has not driven since intake, and the handgun has been taken out of the home. His new hearing aids were fitted last week, and he says the television is clearer. He wants to settle who will speak for him while he can still decide it himself. [S]
| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 63 |
| Memory | Mild dementia due to Alzheimer's disease; donepezil 5 mg |
| Diabetes | Glipizide stopped; home glucose 120 to 170 mg/dL, no lows |
| Mood | PHQ-2 0 |
| Hearing | Hearing aids fitted last week |
Health risk assessment. Completed with him and his care partner at the visit, with large print and one question at a time, and reviewed by Dr. Pryce-Okonjo. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Good, apart from his memory |
| Psychosocial | Lives with his care partner; friends from boxing; visits the foundation gym |
| Alcohol | A glass of wine on special occasions |
| Tobacco | Never smoked |
| Physical activity | Walks an hour and skips rope most days |
| Nutrition | Two large meals a day; fewer sweets since the diabetes review |
| Sleep | Sleeps seven hours without the over-the-counter sleep aid; light snoring, no pauses noticed by his care partner |
| Safety at home | No firearm in the home; stove left on once, now with an automatic shut-off |
| Falls | No falls |
| Activities of daily living | Independent in personal care; help with bills, medicines and appointments |
| Hearing and vision | Hearing aids since last week; reading glasses |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever, night sweats or unplanned weight loss |
| Eyes | Negative | No loss of vision |
| Ears, nose, mouth, and throat | Positive | Hearing loss, better with hearing aids |
| Cardiovascular | Negative | No chest pain, palpitations or fainting |
| Respiratory | Negative | No cough or shortness of breath |
| Gastrointestinal | Negative | No nausea or diarrhea on donepezil 5 mg |
| Genitourinary | Negative | Gets up once at night to pass urine |
| Musculoskeletal | Negative | Stiff hands in the morning, no swelling |
| Integumentary | Negative | No foot sores |
| Neurological | Positive | Memory loss; no weakness, tremor or falls |
| Psychiatric | Negative | Mood good; PHQ-2 0 |
11 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Metformin 1,000 mg oral tablet, one tablet twice daily with meals | One tablet twice daily with meals | Oral route | 2024-03-01 | active | S |
| Glipizide 5 mg oral tablet, one tablet before breakfast | One tablet before breakfast | Oral route | 2025-01-15 to 2026-08-18 | completed | S |
| Lisinopril 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2023-06-01 | active | S |
| Atorvastatin 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2024-03-01 | active | S |
| Diphenhydramine 25 mg oral capsule, one at bedtime for sleep, bought over the counter | One capsule at bedtime | Oral route | 2025-10-01 to 2026-07-07 | stopped | S |
| Donepezil 5 mg oral tablet, one tablet at bedtime | One tablet at bedtime | Oral route | 2026-08-18 to 2026-09-22 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-09-08 | Body height | 180 | cm | S |
| 2026-09-08 | Body weight | 76.4 | kg | S |
| 2026-09-08 | Body mass index (BMI) [Ratio] | 23.6 | kg/m2 | S |
| 2026-09-08 | Systolic blood pressure | 126 | mm[Hg] | S |
| 2026-09-08 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-09-08 | Heart rate | 68 | /min | S |
| 2026-09-08 | Respiratory rate | 14 | /min | S |
| 2026-09-08 | Body temperature | 36.6 | Cel | S |
| 2026-09-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-09-08 | Cholesterol [Mass/volume] in Serum or Plasma | 154 | mg/dL | <=199 mg/dL | Normal | S |
| 2026-09-08 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 49 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-09-08 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 79 | mg/dL | <=99 mg/dL | Normal | S |
| 2026-09-08 | Triglyceride [Mass/volume] in Serum or Plasma | 128 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-09-08 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S |
Vital signs recorded on 2026-09-08; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well and cheerful; weight 76.4 kg, BMI 23.6; blood pressure 126/76; pulse 68 |
| Eyes | Visual acuity 20/30 each eye with reading glasses; old scarring of both brows |
| Ears | Hearing aids in place; canals clear |
| Cardiovascular | Regular rhythm; no murmur; foot pulses normal |
| Respiratory | Clear to auscultation |
| Abdomen | Soft and non-tender |
| Feet | Comprehensive diabetic foot examination: skin intact, no deformity; 10-g monofilament, pinprick and vibration sensation normal |
| Neurological | No tremor, rigidity or slowness of movement; steady gait |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Memory loss over about two years, worse in the past six months, with repeated questions, missed appointments and bills, and getting lost twice while driving in familiar streets, reported by him and his care partner; cause to be found | resolved | confirmed | R41.3 | S — Synthetic presenting problem anchored to his documented Alzheimer's disease; resolved into the diagnosis at the third visit. Not a claim about his real symptoms at that age. |
| Alzheimer's disease with early onset, confirmed by a positive amyloid PET, with an amnestic presentation; traumatic encephalopathy syndrome, a research diagnosis, considered | active | confirmed | G30.0 | S — Synthetic modern diagnosis by current criteria at the third visit; not a retrospective diagnosis of the historical person beyond the documented Alzheimer's disease. |
| Mild dementia due to Alzheimer's disease (CDR 1, MMSE 22, MoCA 18), without behavioral or psychological symptoms | active | confirmed | F02.A0 | S — Synthetic stage at diagnosis. |
| Type 2 diabetes for about ten years on metformin and glipizide; hemoglobin A1c 6.4%, below his goal, with hypoglycemia risk from the sulfonylurea | active | confirmed | E11.9 | S — Synthetic modern diabetes anchored to his documented diabetes. |
| Hypertension, controlled on lisinopril | active | confirmed | I10 | S — Synthetic modern hypertension anchored to the single press report. |
| Bilateral sensorineural hearing loss, mild to moderate, high frequencies, on audiometry | active | confirmed | H90.3 | S — Synthetic finding checked as a modifiable contributor to cognitive difficulty. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure | Completed today | 126/76 mmHg on lisinopril |
| Colorectal cancer screening | Up to date | Colonoscopy six years ago, normal; next due in four years |
| Prostate cancer screening | Declined | Shared decision-making for men 55 to 69; he chose not to be tested |
| Lung cancer screening | Not indicated | Never smoked |
| Abdominal aortic aneurysm screening | Not indicated | Recommended for men 65 to 75 who have ever smoked |
| Lipid screening and statin | Completed today | Total cholesterol 154, HDL 49, LDL 79, triglycerides 128 mg/dL on atorvastatin 20 mg |
| Diabetic foot examination | Completed today | Normal, with monofilament |
| Diabetic eye examination | Referred | Requested at intake and not yet done; booked with transport now that he does not drive |
| HIV screening | Completed today | Offered and accepted; one-time screening |
| Hepatitis C screening | Completed today | Offered and accepted; one-time screening |
| Hepatitis B screening | Completed today | Triple panel, recommended once for all adults |
| Depression screening | Completed today | PHQ-2 0 |
| Unhealthy alcohol use | Completed today | A glass of wine on special occasions |
| Tobacco cessation | Not indicated | Never smoked |
| Influenza vaccine | Completed today | For the coming season |
| Pneumococcal vaccine | Completed today | PCV20 today; recommended for all adults 50 and older |
| Recombinant zoster vaccine | Completed today | First of two doses; second in two to six months |
| Tetanus, diphtheria, and pertussis | Due | No booster he can recall; he chose Tdap at the next visit rather than a fourth injection today |
| RSV vaccine | Not indicated | For adults 50 to 74 only with certain conditions; his diabetes has no complications and needs neither insulin nor an SGLT2 inhibitor; due at 75 |
| COVID-19 vaccine | Declined | Offered for the coming season; he will decide with his care partner |
Immunizations given today: Influenza vaccine for the coming season; Pneumococcal conjugate vaccine (PCV20), recommended for all adults aged 50 and older; Recombinant zoster vaccine, first of two doses [S]
Guideline basis: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); 13. Older Adults: Standards of Care in Diabetes-2026 (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)
Follow-up: Eleven-week review in two weeks, with hemoglobin A1c and Tdap. Screening results by phone. Eye examination as booked. Second zoster dose in two to six months. Next preventive visit in one year. Next scheduled visit 2026-09-22: eleven-week review: donepezil dose, diabetes, hearing aids and day program. [S]
Voluntary advance care planning discussion of about 30 minutes with him and his care partner, at his request, while he can take part fully. His capacity for these decisions was assessed: he understood what a health care agent does, could explain why he chose his agent, and gave consistent answers. He named his care partner as his health care agent on a durable power of attorney for health care; the agent is recorded in the chart and is not named here. He said that what matters most is staying at home, being with the people close to him, and keeping his dignity; that he wants to keep going to the gym while he can; and that if he no longer knows the people close to him, he wants care focused on comfort at home, with no feeding tube and no machines to keep him alive. A financial power of attorney was discussed and he will arrange it. The plan will be revisited every six months and at any change in his condition. [S]